FindTrial
Sign In

A study to compare two drugs when added to levobupivacaine in lower limb surgeries

A comparison of intrathecal dexmedetomidine and fentanyl as an adjuvant to 0.5% levobupivacaine in lower limb surgeries: A randomised double blind study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036808
Enrollment
72
Registered
2021-09-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Dexmedetomidine (3 mcg) and 0.5% levobupivacaine (15 mg) intrathecally: Dexmedetomidine is aplha-2 agonist used as adjuvant Levobupivacaine is local anaesthetic agent Control Interventi

Sponsors

Rohilkhand medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA I or II Age between 19 to 65 years Either sex Patient posted for elective lower limb surgery

Exclusion criteria

Exclusion criteria: Patient refusal for procedure Patientâ??s contraindications to spinal anaesthesia (eg: deranged coagulation profile ) Obesity (BMI >30kg/m2) Any neuropathies Patients receiving Opioids for chronic analgesic therapy Allergy or intolerance to local anaesthetics Patients on beta-blocker or known dysrhythmia

Design outcomes

Primary

MeasureTime frame
Onset and duration of motor and sensory blockadeTimepoint: On Day 1—

Secondary

MeasureTime frame
Haemodynamic changes , post - op shivering and emesisTimepoint: On Day 1—

Countries

India

Contacts

Public ContactDr Neeharika Arora

Rohilkhand medical college and hospital

docneehars@gmail.com8077104070

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026